Revenue integrity professionals often run across tough questions. On the NAHRI Forums, revenue integrity professionals can get advice from peers and experts and learn about solutions others have discovered. Here are the questions that have sparked the most conversation.
CMS’ rules for inpatient admission can leave providers questioning when it’s appropriate to admit a patient presenting with an uncomplicated myocardial infarction.
Clinical research studies can offer enormous benefits for patients and provider organizations. But managing charges and submitting claims for clinical research can throw a curveball at revenue integrity teams. Without efficient charge and edit management processes, revenue integrity could find itself striking out.
More than 100 NAHRI members tuned in to hear expert advice on revenue integrity hot topics and get the scoop about exciting new NAHRI initiatives during our second members-only quarterly call on April 24.
CMS released the fiscal year (FY) 2019 IPPS proposed rule on Tuesday, April 24, with an overhaul of the Meaningful Use program and significant reductions to reporting requirements for quality initiatives, along with updates to payment rates.
Q: Over the last few weeks, there have been quite a few articles in various newsletters about device credits. I’m not sure we have the best process in place to identify recalls and under-warranty replacements so I took a look. In the first account I reviewed, I found an item from a St. Jude recall. When I shared my findings with my compliance officer, the response was, “Why are you looking?” Should I not look?
